{
  "retracted": false,
  "timestamp": 1563840000000,
  "updates": [
    {
      "timestamp": 1566805221631,
      "identifier": {
        "doi": "10.1007/s40261-019-00832-2"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s40261-019-00807-3"
  },
  "journal": "Clinical Drug Investigation",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel NaV1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy Volunteers"
}
